OTCPK:EUCTF - Post by User
Comment by
newdaydawningon Aug 17, 2017 7:30pm
38 Views
Post# 26594251
RE:RE:RE:RE:RE:RE:Xwinsys will succeed
RE:RE:RE:RE:RE:RE:Xwinsys will succeedKid, not sure why you have such disdain for R&D - the lifeblood companies like EUO. What makes EUO so compelling, IMO, is that has a technology platform, EDXRF, which is being constantly re-used across a raft of applications in all three subsidiaries.
kidl2 wrote: Raptot: You are beyond help and so are the people who are bidding on current cash value.
Cash in a MC is trash (which gets taken out by insiders) unless it’s put to use. Use which benefits shareholders and this has not been the case ever since EUO was conceived / Bruce came on the scene.
Xenemetrix will at best maintain Q1 revenues, Netafim and XwinSys will have sucked out more R&D dollars which is very much to Doron’s liking as it affirms his “kingpin” position.
You are listening to a person who is nothing more than a “willing” front to a vehicle designed to ...
I’ll leave it with the 3 dots. Shareholders can complete the sentence any which way they want.
I make a habit of getting to know the companies I (seriously) play with very well as I’ve been caught too many times.
I used to subscribe to the “If it looks like a duck, behaves like a duck, smells like a duck” scenario. I have long ago graduated to the “The smell is enough” scenario and it has served me well.
If any of the EUO subs produce any sales of any consequence by the end of this year, I’ll eat my shirt. I’ll actually do better than that. I will stop posting on this forum if XwinSys sells a single (paid for) unit by that time.
I said this before and I’ll say it again ... EUO had a unique chance 2 years ago with millions of dollars of fresh cash. Instead of deploying this cash to revenue / profit producing ventures, it went into the bottomless Doron R&D pit.
New Xenemetrix gismos which did nothing for sales aside from a one-time SICPA order.
A new / expanded XwinSys horizon which essentially killed any short term prospects.
This nothing short of puzzling Croptimal venture which promotes the possibility of eliminating existing labs. Labs which multi billion dollar companies have invested mega-bucks in and thus must only too happy to throw to the scrap heap.
What am I missing here?